Common Side Effects of Cosentyx
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, causes upper respiratory infections in 14-18% of patients, diarrhea in 4-11%, and nasopharyngitis in up to 11%.[1] Injection-site reactions occur in 3-5%, with rare serious risks like increased infections (e.g., candida in 3-4%), inflammatory bowel disease flares, and hypersensitivity reactions. Long-term data show tuberculosis reactivation in <0.1%.[1][2]
Common Side Effects of Flu Shots
Flu vaccines (inactivated or recombinant types) trigger mild reactions in 10-64% of recipients: soreness at injection site (10-64%), fatigue (13-34%), headache (8-26%), muscle pain (9-25%), and low-grade fever (<1-3%). These peak within 24-48 hours and resolve in 1-2 days. Serious allergic reactions (anaphylaxis) affect 1-2 per million doses; Guillain-Barré syndrome risk is 1-2 excess cases per million.[3][4]
Key Differences in Side Effect Profiles
Cosentyx side effects are mostly chronic or delayed—respiratory infections and GI issues persist during treatment (up to 5% discontinuation rate)—while flu shot effects are transient and self-limiting.[1][3] Cosentyx carries higher infection risk due to immune suppression (odds ratio 1.5-2 for serious infections), absent in flu shots.[2] Flu shots have negligible systemic immunosuppression but rare neurological risks like Guillain-Barré, not seen with Cosentyx.[4] Both share injection-site reactions, but Cosentyx's are less frequent (3% vs. up to 64%).
| Aspect | Cosentyx | Flu Shot |
|--------|----------|----------|
| Frequency of mild effects | 10-20% ongoing | 10-64% (1-2 days) |
| Main types | Infections, diarrhea | Soreness, fatigue, headache |
| Serious risks | IBD, TB reactivation (<1%) | Anaphylaxis, GBS (<<1%) |
| Duration | Weeks to months | Hours to days |
Patient Considerations and Overlap Risks
Patients on Cosentyx can safely get flu shots; guidelines recommend them to counter heightened infection vulnerability (e.g., influenza hospitalization risk doubles with biologics).[2][5] No increased adverse events from co-administration in studies, though monitor for amplified mild reactions. Flu shots do not exacerbate Cosentyx's GI or skin effects.[5] Consult providers for live attenuated flu vaccines (contraindicated with immunosuppression).[3]
[1] Cosentyx Prescribing Information, Novartis, 2023. https://www.cosentyx.com
[2] DrugPatentWatch.com analysis of secukinumab adverse events. https://www.drugpatentwatch.com/p/tradename/COSENTYX
[3] CDC Flu Vaccine Safety, 2023. https://www.cdc.gov/flu/prevent/keyfacts.htm
[4] VAERS Flu Vaccine Data Summary, 2023. https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html
[5] ACR Guidelines on Vaccinations in Rheumatic Diseases, 2021. https://rheumatology.org